nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—atherosclerosis	0.24	1	CbGaD
Pethidine—ALB—Rosuvastatin—atherosclerosis	0.0725	0.139	CbGbCtD
Pethidine—CYP2B6—Simvastatin—atherosclerosis	0.0688	0.132	CbGbCtD
Pethidine—CYP2C19—Rosuvastatin—atherosclerosis	0.047	0.0899	CbGbCtD
Pethidine—CYP2C19—Simvastatin—atherosclerosis	0.0437	0.0836	CbGbCtD
Pethidine—CYP2C19—Lovastatin—atherosclerosis	0.0428	0.0818	CbGbCtD
Pethidine—CYP2D6—Niacin—atherosclerosis	0.042	0.0804	CbGbCtD
Pethidine—CYP2D6—Simvastatin—atherosclerosis	0.0332	0.0635	CbGbCtD
Pethidine—CYP2D6—Lovastatin—atherosclerosis	0.0325	0.0622	CbGbCtD
Pethidine—CYP2D6—Pravastatin—atherosclerosis	0.0325	0.0622	CbGbCtD
Pethidine—CYP3A4—Rosuvastatin—atherosclerosis	0.0227	0.0435	CbGbCtD
Pethidine—CYP3A4—Ezetimibe—atherosclerosis	0.0227	0.0435	CbGbCtD
Pethidine—CYP3A4—Simvastatin—atherosclerosis	0.0211	0.0404	CbGbCtD
Pethidine—CYP3A4—Pravastatin—atherosclerosis	0.0207	0.0395	CbGbCtD
Pethidine—CYP3A4—Lovastatin—atherosclerosis	0.0207	0.0395	CbGbCtD
Pethidine—Fibrosis—Niacin—atherosclerosis	0.00573	0.0634	CcSEcCtD
Pethidine—Muscle twitching—Niacin—atherosclerosis	0.00167	0.0184	CcSEcCtD
Pethidine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00118	0.013	CcSEcCtD
Pethidine—Affect lability—Pravastatin—atherosclerosis	0.00115	0.0127	CcSEcCtD
Pethidine—Urinary retention—Niacin—atherosclerosis	0.00113	0.0125	CcSEcCtD
Pethidine—Mood swings—Pravastatin—atherosclerosis	0.00111	0.0123	CcSEcCtD
Pethidine—Orthostatic hypotension—Niacin—atherosclerosis	0.00108	0.012	CcSEcCtD
Pethidine—Flushing—Lovastatin—atherosclerosis	0.000888	0.00983	CcSEcCtD
Pethidine—Sweating—Niacin—atherosclerosis	0.000878	0.00971	CcSEcCtD
Pethidine—Flushing—Ezetimibe—atherosclerosis	0.000871	0.00964	CcSEcCtD
Pethidine—Flushing—Simvastatin—atherosclerosis	0.000831	0.00919	CcSEcCtD
Pethidine—Erythema—Ezetimibe—atherosclerosis	0.000817	0.00904	CcSEcCtD
Pethidine—Confusional state—Rosuvastatin—atherosclerosis	0.000809	0.00895	CcSEcCtD
Pethidine—Muscle spasms—Lovastatin—atherosclerosis	0.000801	0.00886	CcSEcCtD
Pethidine—Visual impairment—Niacin—atherosclerosis	0.000792	0.00876	CcSEcCtD
Pethidine—Muscle spasms—Ezetimibe—atherosclerosis	0.000785	0.00869	CcSEcCtD
Pethidine—Tremor—Lovastatin—atherosclerosis	0.00078	0.00864	CcSEcCtD
Pethidine—Visual impairment—Pravastatin—atherosclerosis	0.00078	0.00863	CcSEcCtD
Pethidine—Erythema—Simvastatin—atherosclerosis	0.000779	0.00862	CcSEcCtD
Pethidine—Flushing—Niacin—atherosclerosis	0.000763	0.00844	CcSEcCtD
Pethidine—Flushing—Pravastatin—atherosclerosis	0.000751	0.00831	CcSEcCtD
Pethidine—Muscle spasms—Simvastatin—atherosclerosis	0.000749	0.00829	CcSEcCtD
Pethidine—Vertigo—Lovastatin—atherosclerosis	0.000748	0.00828	CcSEcCtD
Pethidine—Tremor—Simvastatin—atherosclerosis	0.00073	0.00808	CcSEcCtD
Pethidine—Insomnia—Rosuvastatin—atherosclerosis	0.000725	0.00803	CcSEcCtD
Pethidine—Palpitations—Ezetimibe—atherosclerosis	0.000722	0.00799	CcSEcCtD
Pethidine—Erythema—Niacin—atherosclerosis	0.000715	0.00792	CcSEcCtD
Pethidine—Anxiety—Lovastatin—atherosclerosis	0.000707	0.00782	CcSEcCtD
Pethidine—Hypertension—Ezetimibe—atherosclerosis	0.000705	0.00781	CcSEcCtD
Pethidine—Vertigo—Simvastatin—atherosclerosis	0.0007	0.00775	CcSEcCtD
Pethidine—Dry mouth—Lovastatin—atherosclerosis	0.000693	0.00767	CcSEcCtD
Pethidine—Muscle spasms—Niacin—atherosclerosis	0.000688	0.00761	CcSEcCtD
Pethidine—Constipation—Rosuvastatin—atherosclerosis	0.000686	0.00759	CcSEcCtD
Pethidine—Confusional state—Lovastatin—atherosclerosis	0.000685	0.00759	CcSEcCtD
Pethidine—Dry mouth—Ezetimibe—atherosclerosis	0.00068	0.00753	CcSEcCtD
Pethidine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00068	0.00752	CcSEcCtD
Pethidine—Muscle spasms—Pravastatin—atherosclerosis	0.000677	0.00749	CcSEcCtD
Pethidine—Confusional state—Ezetimibe—atherosclerosis	0.000672	0.00744	CcSEcCtD
Pethidine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000667	0.00738	CcSEcCtD
Pethidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000661	0.00731	CcSEcCtD
Pethidine—Anxiety—Simvastatin—atherosclerosis	0.000661	0.00731	CcSEcCtD
Pethidine—Tremor—Pravastatin—atherosclerosis	0.00066	0.0073	CcSEcCtD
Pethidine—Anorexia—Lovastatin—atherosclerosis	0.000648	0.00717	CcSEcCtD
Pethidine—Vertigo—Niacin—atherosclerosis	0.000643	0.00711	CcSEcCtD
Pethidine—Syncope—Niacin—atherosclerosis	0.000641	0.0071	CcSEcCtD
Pethidine—Confusional state—Simvastatin—atherosclerosis	0.000641	0.00709	CcSEcCtD
Pethidine—Urticaria—Rosuvastatin—atherosclerosis	0.000637	0.00705	CcSEcCtD
Pethidine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000636	0.00704	CcSEcCtD
Pethidine—Oedema—Simvastatin—atherosclerosis	0.000636	0.00704	CcSEcCtD
Pethidine—Vertigo—Pravastatin—atherosclerosis	0.000633	0.007	CcSEcCtD
Pethidine—Palpitations—Niacin—atherosclerosis	0.000632	0.007	CcSEcCtD
Pethidine—Loss of consciousness—Niacin—atherosclerosis	0.000629	0.00696	CcSEcCtD
Pethidine—Insomnia—Lovastatin—atherosclerosis	0.000615	0.0068	CcSEcCtD
Pethidine—Hypertension—Pravastatin—atherosclerosis	0.000608	0.00673	CcSEcCtD
Pethidine—Anorexia—Simvastatin—atherosclerosis	0.000606	0.00671	CcSEcCtD
Pethidine—Insomnia—Ezetimibe—atherosclerosis	0.000603	0.00667	CcSEcCtD
Pethidine—Anxiety—Pravastatin—atherosclerosis	0.000598	0.00661	CcSEcCtD
Pethidine—Dry mouth—Niacin—atherosclerosis	0.000596	0.00659	CcSEcCtD
Pethidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000591	0.00654	CcSEcCtD
Pethidine—Decreased appetite—Lovastatin—atherosclerosis	0.000591	0.00654	CcSEcCtD
Pethidine—Oedema—Niacin—atherosclerosis	0.000584	0.00646	CcSEcCtD
Pethidine—Anaphylactic shock—Niacin—atherosclerosis	0.000584	0.00646	CcSEcCtD
Pethidine—Constipation—Lovastatin—atherosclerosis	0.000581	0.00643	CcSEcCtD
Pethidine—Confusional state—Pravastatin—atherosclerosis	0.00058	0.00641	CcSEcCtD
Pethidine—Decreased appetite—Ezetimibe—atherosclerosis	0.00058	0.00641	CcSEcCtD
Pethidine—Asthenia—Rosuvastatin—atherosclerosis	0.000575	0.00637	CcSEcCtD
Pethidine—Insomnia—Simvastatin—atherosclerosis	0.000575	0.00636	CcSEcCtD
Pethidine—Oedema—Pravastatin—atherosclerosis	0.000575	0.00636	CcSEcCtD
Pethidine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000575	0.00636	CcSEcCtD
Pethidine—Shock—Niacin—atherosclerosis	0.000574	0.00636	CcSEcCtD
Pethidine—Constipation—Ezetimibe—atherosclerosis	0.00057	0.00631	CcSEcCtD
Pethidine—Tachycardia—Niacin—atherosclerosis	0.00057	0.00631	CcSEcCtD
Pethidine—Pruritus—Rosuvastatin—atherosclerosis	0.000567	0.00628	CcSEcCtD
Pethidine—Hyperhidrosis—Niacin—atherosclerosis	0.000564	0.00625	CcSEcCtD
Pethidine—Feeling abnormal—Lovastatin—atherosclerosis	0.00056	0.0062	CcSEcCtD
Pethidine—Anorexia—Niacin—atherosclerosis	0.000556	0.00616	CcSEcCtD
Pethidine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000556	0.00615	CcSEcCtD
Pethidine—Decreased appetite—Simvastatin—atherosclerosis	0.000553	0.00612	CcSEcCtD
Pethidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000549	0.00608	CcSEcCtD
Pethidine—Anorexia—Pravastatin—atherosclerosis	0.000548	0.00606	CcSEcCtD
Pethidine—Hypotension—Niacin—atherosclerosis	0.000546	0.00604	CcSEcCtD
Pethidine—Constipation—Simvastatin—atherosclerosis	0.000544	0.00602	CcSEcCtD
Pethidine—Urticaria—Lovastatin—atherosclerosis	0.00054	0.00598	CcSEcCtD
Pethidine—Dizziness—Rosuvastatin—atherosclerosis	0.00053	0.00587	CcSEcCtD
Pethidine—Urticaria—Ezetimibe—atherosclerosis	0.00053	0.00586	CcSEcCtD
Pethidine—Insomnia—Niacin—atherosclerosis	0.000528	0.00584	CcSEcCtD
Pethidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000524	0.0058	CcSEcCtD
Pethidine—Insomnia—Pravastatin—atherosclerosis	0.00052	0.00575	CcSEcCtD
Pethidine—Somnolence—Niacin—atherosclerosis	0.000519	0.00574	CcSEcCtD
Pethidine—Decreased appetite—Niacin—atherosclerosis	0.000507	0.00562	CcSEcCtD
Pethidine—Rash—Rosuvastatin—atherosclerosis	0.000506	0.0056	CcSEcCtD
Pethidine—Dermatitis—Rosuvastatin—atherosclerosis	0.000505	0.00559	CcSEcCtD
Pethidine—Urticaria—Simvastatin—atherosclerosis	0.000505	0.00559	CcSEcCtD
Pethidine—Headache—Rosuvastatin—atherosclerosis	0.000502	0.00556	CcSEcCtD
Pethidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000501	0.00554	CcSEcCtD
Pethidine—Decreased appetite—Pravastatin—atherosclerosis	0.0005	0.00553	CcSEcCtD
Pethidine—Constipation—Pravastatin—atherosclerosis	0.000492	0.00544	CcSEcCtD
Pethidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000491	0.00544	CcSEcCtD
Pethidine—Asthenia—Lovastatin—atherosclerosis	0.000488	0.0054	CcSEcCtD
Pethidine—Pruritus—Lovastatin—atherosclerosis	0.000481	0.00532	CcSEcCtD
Pethidine—Asthenia—Ezetimibe—atherosclerosis	0.000478	0.00529	CcSEcCtD
Pethidine—Nausea—Rosuvastatin—atherosclerosis	0.000476	0.00527	CcSEcCtD
Pethidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000474	0.00524	CcSEcCtD
Pethidine—Pruritus—Ezetimibe—atherosclerosis	0.000472	0.00522	CcSEcCtD
Pethidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000468	0.00518	CcSEcCtD
Pethidine—Urticaria—Niacin—atherosclerosis	0.000464	0.00513	CcSEcCtD
Pethidine—Urticaria—Pravastatin—atherosclerosis	0.000457	0.00505	CcSEcCtD
Pethidine—Asthenia—Simvastatin—atherosclerosis	0.000456	0.00505	CcSEcCtD
Pethidine—Pruritus—Simvastatin—atherosclerosis	0.00045	0.00498	CcSEcCtD
Pethidine—Dizziness—Lovastatin—atherosclerosis	0.000449	0.00497	CcSEcCtD
Pethidine—Dizziness—Ezetimibe—atherosclerosis	0.000441	0.00488	CcSEcCtD
Pethidine—Vomiting—Lovastatin—atherosclerosis	0.000432	0.00478	CcSEcCtD
Pethidine—Hypersensitivity—Niacin—atherosclerosis	0.00043	0.00476	CcSEcCtD
Pethidine—Rash—Lovastatin—atherosclerosis	0.000429	0.00474	CcSEcCtD
Pethidine—Dermatitis—Lovastatin—atherosclerosis	0.000428	0.00474	CcSEcCtD
Pethidine—Headache—Lovastatin—atherosclerosis	0.000426	0.00471	CcSEcCtD
Pethidine—Vomiting—Ezetimibe—atherosclerosis	0.000424	0.00469	CcSEcCtD
Pethidine—Hypersensitivity—Pravastatin—atherosclerosis	0.000423	0.00469	CcSEcCtD
Pethidine—Dizziness—Simvastatin—atherosclerosis	0.00042	0.00465	CcSEcCtD
Pethidine—Rash—Ezetimibe—atherosclerosis	0.00042	0.00465	CcSEcCtD
Pethidine—Dermatitis—Ezetimibe—atherosclerosis	0.00042	0.00465	CcSEcCtD
Pethidine—Asthenia—Niacin—atherosclerosis	0.000419	0.00464	CcSEcCtD
Pethidine—Headache—Ezetimibe—atherosclerosis	0.000418	0.00462	CcSEcCtD
Pethidine—Pruritus—Niacin—atherosclerosis	0.000413	0.00457	CcSEcCtD
Pethidine—Asthenia—Pravastatin—atherosclerosis	0.000412	0.00456	CcSEcCtD
Pethidine—Pruritus—Pravastatin—atherosclerosis	0.000407	0.0045	CcSEcCtD
Pethidine—Vomiting—Simvastatin—atherosclerosis	0.000404	0.00447	CcSEcCtD
Pethidine—Nausea—Lovastatin—atherosclerosis	0.000404	0.00447	CcSEcCtD
Pethidine—Rash—Simvastatin—atherosclerosis	0.000401	0.00444	CcSEcCtD
Pethidine—Dermatitis—Simvastatin—atherosclerosis	0.000401	0.00443	CcSEcCtD
Pethidine—Headache—Simvastatin—atherosclerosis	0.000398	0.00441	CcSEcCtD
Pethidine—Nausea—Ezetimibe—atherosclerosis	0.000396	0.00438	CcSEcCtD
Pethidine—Dizziness—Niacin—atherosclerosis	0.000386	0.00427	CcSEcCtD
Pethidine—Dizziness—Pravastatin—atherosclerosis	0.00038	0.00421	CcSEcCtD
Pethidine—Nausea—Simvastatin—atherosclerosis	0.000378	0.00418	CcSEcCtD
Pethidine—Vomiting—Niacin—atherosclerosis	0.000371	0.00411	CcSEcCtD
Pethidine—Rash—Niacin—atherosclerosis	0.000368	0.00407	CcSEcCtD
Pethidine—Dermatitis—Niacin—atherosclerosis	0.000368	0.00407	CcSEcCtD
Pethidine—Headache—Niacin—atherosclerosis	0.000366	0.00405	CcSEcCtD
Pethidine—Vomiting—Pravastatin—atherosclerosis	0.000365	0.00404	CcSEcCtD
Pethidine—Rash—Pravastatin—atherosclerosis	0.000362	0.00401	CcSEcCtD
Pethidine—Dermatitis—Pravastatin—atherosclerosis	0.000362	0.00401	CcSEcCtD
Pethidine—Headache—Pravastatin—atherosclerosis	0.00036	0.00399	CcSEcCtD
Pethidine—Nausea—Niacin—atherosclerosis	0.000347	0.00384	CcSEcCtD
Pethidine—Nausea—Pravastatin—atherosclerosis	0.000341	0.00378	CcSEcCtD
Pethidine—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.51e-05	0.000103	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	1.51e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—BGN—atherosclerosis	1.5e-05	0.000103	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.5e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.5e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.5e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.5e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.49e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOA5—atherosclerosis	1.49e-05	0.000102	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.48e-05	0.000101	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.48e-05	0.000101	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	1.47e-05	0.0001	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SPP1—atherosclerosis	1.47e-05	0.0001	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	1.46e-05	9.99e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.45e-05	9.88e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.43e-05	9.8e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF1—atherosclerosis	1.43e-05	9.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LPA—atherosclerosis	1.43e-05	9.76e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.42e-05	9.74e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.42e-05	9.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP3—atherosclerosis	1.42e-05	9.7e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.42e-05	9.68e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF2—atherosclerosis	1.41e-05	9.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.4e-05	9.6e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.4e-05	9.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.38e-05	9.46e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BGN—atherosclerosis	1.38e-05	9.45e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NAMPT—atherosclerosis	1.38e-05	9.45e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.38e-05	9.4e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—LIPC—atherosclerosis	1.37e-05	9.39e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.37e-05	9.37e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.37e-05	9.36e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOC3—atherosclerosis	1.37e-05	9.33e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SERPINE1—atherosclerosis	1.36e-05	9.3e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.36e-05	9.3e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	1.36e-05	9.28e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—LDLR—atherosclerosis	1.36e-05	9.28e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.35e-05	9.23e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.34e-05	9.15e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CETP—atherosclerosis	1.33e-05	9.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AGT—atherosclerosis	1.33e-05	9.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.32e-05	9.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.31e-05	8.95e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—LEP—atherosclerosis	1.3e-05	8.88e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOE—atherosclerosis	1.3e-05	8.88e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NOS3—atherosclerosis	1.3e-05	8.88e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CAV1—atherosclerosis	1.29e-05	8.8e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOA1—atherosclerosis	1.28e-05	8.78e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.28e-05	8.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.27e-05	8.7e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.27e-05	8.7e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—SCARB1—atherosclerosis	1.27e-05	8.68e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.27e-05	8.68e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.24e-05	8.49e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.24e-05	8.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ESR1—atherosclerosis	1.24e-05	8.48e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.24e-05	8.44e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.23e-05	8.44e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.23e-05	8.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.23e-05	8.42e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.23e-05	8.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—F2—atherosclerosis	1.23e-05	8.37e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.22e-05	8.33e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMGCR—atherosclerosis	1.2e-05	8.2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CETP—atherosclerosis	1.19e-05	8.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.17e-05	8.01e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.16e-05	7.92e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.16e-05	7.92e-05	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.16e-05	7.92e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.15e-05	7.84e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.14e-05	7.8e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.14e-05	7.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.14e-05	7.77e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.13e-05	7.76e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.13e-05	7.71e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.12e-05	7.67e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.12e-05	7.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.12e-05	7.66e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.12e-05	7.64e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.11e-05	7.59e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—INS—atherosclerosis	1.11e-05	7.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.1e-05	7.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.1e-05	7.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CETP—atherosclerosis	1.09e-05	7.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.09e-05	7.46e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.09e-05	7.44e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.09e-05	7.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.09e-05	7.42e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.08e-05	7.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.08e-05	7.36e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.07e-05	7.34e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCA1—atherosclerosis	1.07e-05	7.3e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.05e-05	7.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.05e-05	7.16e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOB—atherosclerosis	1.04e-05	7.13e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—F2—atherosclerosis	1.04e-05	7.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.03e-05	7.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.02e-05	6.97e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.02e-05	6.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—LPL—atherosclerosis	9.96e-06	6.81e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	9.91e-06	6.77e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.9e-06	6.77e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.79e-06	6.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA2—atherosclerosis	9.79e-06	6.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.79e-06	6.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.79e-06	6.69e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOS3—atherosclerosis	9.73e-06	6.65e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GPX1—atherosclerosis	9.72e-06	6.64e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.71e-06	6.64e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.67e-06	6.61e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.6e-06	6.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	9.49e-06	6.49e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CD36—atherosclerosis	9.47e-06	6.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INS—atherosclerosis	9.38e-06	6.41e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—atherosclerosis	9.36e-06	6.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LPA—atherosclerosis	9.34e-06	6.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL2—atherosclerosis	9.23e-06	6.31e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—atherosclerosis	9.17e-06	6.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—atherosclerosis	9.07e-06	6.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BGN—atherosclerosis	9.05e-06	6.18e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.97e-06	6.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.95e-06	6.12e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—atherosclerosis	8.85e-06	6.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.83e-06	6.03e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARA—atherosclerosis	8.8e-06	6.01e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOB—atherosclerosis	8.78e-06	6e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	8.63e-06	5.9e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.62e-06	5.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	8.62e-06	5.89e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—atherosclerosis	8.59e-06	5.87e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—atherosclerosis	8.55e-06	5.84e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AGT—atherosclerosis	8.52e-06	5.83e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—LPL—atherosclerosis	8.39e-06	5.73e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—atherosclerosis	8.35e-06	5.71e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	8.34e-06	5.7e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.32e-06	5.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAV1—atherosclerosis	8.28e-06	5.66e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOA1—atherosclerosis	8.26e-06	5.64e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.23e-06	5.63e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOS3—atherosclerosis	8.23e-06	5.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—atherosclerosis	8.21e-06	5.61e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GPX1—atherosclerosis	8.18e-06	5.59e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CD36—atherosclerosis	7.97e-06	5.45e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOB—atherosclerosis	7.89e-06	5.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—atherosclerosis	7.81e-06	5.34e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	7.73e-06	5.28e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.67e-06	5.24e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	7.59e-06	5.19e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	7.57e-06	5.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.57e-06	5.17e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—atherosclerosis	7.55e-06	5.16e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.54e-06	5.15e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LPL—atherosclerosis	7.53e-06	5.15e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.47e-06	5.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LIPC—atherosclerosis	7.42e-06	5.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARA—atherosclerosis	7.41e-06	5.06e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOC3—atherosclerosis	7.37e-06	5.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPX1—atherosclerosis	7.35e-06	5.02e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LDLR—atherosclerosis	7.33e-06	5.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	7.3e-06	4.99e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—atherosclerosis	7.27e-06	4.97e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOB—atherosclerosis	7.25e-06	4.96e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AGT—atherosclerosis	7.18e-06	4.9e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CETP—atherosclerosis	7.16e-06	4.89e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CD36—atherosclerosis	7.15e-06	4.89e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—INS—atherosclerosis	7.14e-06	4.88e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.06e-06	4.82e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	7.05e-06	4.82e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—atherosclerosis	7.03e-06	4.8e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	7.01e-06	4.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAV1—atherosclerosis	6.97e-06	4.76e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOA1—atherosclerosis	6.95e-06	4.75e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—atherosclerosis	6.94e-06	4.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—atherosclerosis	6.94e-06	4.74e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LPL—atherosclerosis	6.93e-06	4.73e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.86e-06	4.68e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.78e-06	4.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPX1—atherosclerosis	6.76e-06	4.62e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARA—atherosclerosis	6.65e-06	4.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	6.63e-06	4.53e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—atherosclerosis	6.6e-06	4.51e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CD36—atherosclerosis	6.58e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—atherosclerosis	6.54e-06	4.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	6.53e-06	4.46e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.47e-06	4.42e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AGT—atherosclerosis	6.44e-06	4.4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	6.44e-06	4.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	6.42e-06	4.39e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	6.4e-06	4.37e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—atherosclerosis	6.35e-06	4.34e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—atherosclerosis	6.31e-06	4.31e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NOS3—atherosclerosis	6.26e-06	4.28e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAV1—atherosclerosis	6.25e-06	4.27e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOA1—atherosclerosis	6.24e-06	4.26e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.24e-06	4.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—atherosclerosis	6.12e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARA—atherosclerosis	6.12e-06	4.18e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—INS—atherosclerosis	6.01e-06	4.1e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—atherosclerosis	5.97e-06	4.08e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	5.93e-06	4.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AGT—atherosclerosis	5.92e-06	4.05e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—atherosclerosis	5.87e-06	4.01e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—atherosclerosis	5.8e-06	3.97e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.77e-06	3.94e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAV1—atherosclerosis	5.75e-06	3.93e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOA1—atherosclerosis	5.74e-06	3.92e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.72e-06	3.91e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.7e-06	3.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	5.61e-06	3.83e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—atherosclerosis	5.5e-06	3.76e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	5.44e-06	3.72e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—INS—atherosclerosis	5.39e-06	3.68e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NOS3—atherosclerosis	5.27e-06	3.6e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.24e-06	3.58e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—atherosclerosis	5.06e-06	3.46e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—INS—atherosclerosis	4.96e-06	3.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.95e-06	3.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—atherosclerosis	4.94e-06	3.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—atherosclerosis	4.85e-06	3.31e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—atherosclerosis	4.82e-06	3.29e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOB—atherosclerosis	4.74e-06	3.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NOS3—atherosclerosis	4.73e-06	3.23e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.61e-06	3.15e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—atherosclerosis	4.55e-06	3.11e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LPL—atherosclerosis	4.53e-06	3.09e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—atherosclerosis	4.47e-06	3.06e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.42e-06	3.02e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.35e-06	2.97e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.32e-06	2.96e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CD36—atherosclerosis	4.3e-06	2.94e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.1e-06	2.8e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.08e-06	2.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARA—atherosclerosis	4e-06	2.73e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.98e-06	2.72e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AGT—atherosclerosis	3.87e-06	2.65e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—atherosclerosis	3.8e-06	2.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—atherosclerosis	3.78e-06	2.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.76e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.75e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.43e-06	2.34e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.31e-06	2.26e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—INS—atherosclerosis	3.24e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—atherosclerosis	2.97e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—atherosclerosis	2.88e-06	1.97e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.84e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.6e-06	1.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—atherosclerosis	2.42e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.17e-06	1.49e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—atherosclerosis	2e-06	1.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.31e-06	8.93e-06	CbGpPWpGaD
